Bunkerhill MAC vs Zio XT ECG Monitoring System
AI Verdict
Choose Bunkerhill MAC if…
Choose Bunkerhill MAC if your primary objective is to leverage existing routine CT scans to proactively identify and quantify mitral annular calcification (MAC), thereby aiding in early cardiovascular risk stratification. This tool is ideal for integrating an anatomical risk factor into your clinical decision-making and care coordination workflows, especially within the Carebricks platform for automated follow-up.
View Bunkerhill MAC →Choose Zio XT ECG Monitoring System if…
Choose Zio XT ECG Monitoring System if you require continuous, long-term monitoring of a patient's cardiac electrical activity for up to 14 days to detect and diagnose intermittent arrhythmias. This wearable biosensor is best suited for patients experiencing transient symptoms or those needing extended ambulatory monitoring for suspected rhythm disturbances, providing high patient compliance and detailed ECG analysis.
View Zio XT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill MAC | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based, integrates with EHRs. | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemTool B (Zio XT) excels in patient usability with its wearable, lead-free, water-resistant biosensor, promoting high patient compliance (up to 99%) for continuous monitoring. While Tool A (Bunkerhill MAC) offers seamless integration into clinician workflows by utilizing routine CT scans, Tool B's focus on patient comfort directly enhances data quality and diagnostic effectiveness for a wearable device.
Clinical Value
Zio XT ECG Monitoring SystemBoth tools offer significant clinical value with FDA-cleared AI. However, Tool B (Zio XT) provides continuous, long-term cardiac monitoring with high patient compliance, leading to a superior diagnostic yield for intermittent arrhythmias crucial for timely intervention. Tool A (Bunkerhill MAC) identifies a specific cardiovascular risk factor from existing scans, which is valuable but less immediately diagnostic for active conditions.
Pricing & Value
Zio XT ECG Monitoring SystemTool B (Zio XT) offers greater pricing transparency by providing specific per-patient costs in the UK (u00a3310) and proposed Medicare rates in the US ($229-$260.35). In contrast, Tool A (Bunkerhill MAC) only states 'contact for pricing,' making it harder for potential buyers to assess its financial value upfront.
Enterprise Readiness
Zio XT ECG Monitoring SystemTool B (Zio XT) explicitly confirms HIPAA compliance and the existence of a Business Associate Agreement (BAA), which are critical for enterprise healthcare deployments. While Tool A (Bunkerhill MAC) mentions cloud-based deployment and EHR integration, its compliance claims for BAA and HIPAA are stated as 'likely, but not explicitly stated,' making Tool B the more demonstrably enterprise-ready solution.
Innovation
Bunkerhill MACTool A (Bunkerhill MAC) stands out with its application of 'Generative AI for clinical reasoning and action' to detect and quantify mitral annular calcification on routine CT scans. This approach moves beyond simple detection to support broader clinical decision-making and automated workflows, representing a more novel application of AI in healthcare compared to Tool B's refinement of existing cardiac monitoring with deep-learned AI.
Support & Docs
Zio XT ECG Monitoring SystemTool B (Zio XT) offers comprehensive support, including detailed 'Instructions for Use' and 'Clinical Reference Manuals,' a dedicated support section on its website, FAQs, a patient app (MyZio), and 24/7/365 dedicated support teams for various inquiries. Tool A (Bunkerhill MAC) lacks explicit information on dedicated customer support channels or comprehensive documentation in the provided facts or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill MAC | Zio XT ECG Monitoring System |
|---|---|---|
| Name | Bunkerhill MAC | Zio XT ECG Monitoring System |
| Company | Bunkerhill Health | iRhythm Technologies |
| Description | Bunkerhill MAC is an FDA-cleared AI algorithm by Bunkerhill Health that detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification and care coordination within the Carebricks platform. | The Zio XT ECG Monitoring System by iRhythm Technologies offers a wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Key Features | AI-powered detection and quantification of Mitral Annular Calcification (MAC); Analyzes routine, non-gated chest CT scans; Identifies patients at increased cardiovascular risk; Integrates with the Carebricks generative AI platform for clinical reasoning and action; Supports automated workflows for follow-up and care coordination; Developed and validated through a multi-institutional research consortium; Seamless integration with existing EHRs and clinical systems | Wearable single-lead ECG biosensor (Zio biosensor); Continuous ambulatory cardiac monitoring for up to 14 days; Water-resistant design for normal daily activities, including showering; No external leads or wires for enhanced patient comfort and reduced artifacts; Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis; Cloud-based software platform (ZEUS) for data storage, analysis, and reporting; Patient-activated button for symptomatic event logging; High patient compliance (up to 99%) and satisfaction |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill MAC and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Bunkerhill MAC or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.